Details for New Drug Application (NDA): 204722
✉ Email this page to a colleague
The generic ingredient in RIZATRIPTAN BENZOATE is rizatriptan benzoate. There are twenty-two drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the rizatriptan benzoate profile page.
Summary for 204722
Tradename: | RIZATRIPTAN BENZOATE |
Applicant: | Panacea |
Ingredient: | rizatriptan benzoate |
Patents: | 0 |
Pharmacology for NDA: 204722
Mechanism of Action | Serotonin 1b Receptor Agonists Serotonin 1d Receptor Agonists |
Suppliers and Packaging for NDA: 204722
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
RIZATRIPTAN BENZOATE | rizatriptan benzoate | TABLET, ORALLY DISINTEGRATING;ORAL | 204722 | ANDA | Panacea Biotec Limited | 43817-133 | 43817-133-04 | 6 BLISTER PACK in 1 CARTON (43817-133-04) / 3 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (43817-133-03) |
RIZATRIPTAN BENZOATE | rizatriptan benzoate | TABLET, ORALLY DISINTEGRATING;ORAL | 204722 | ANDA | Panacea Biotec Limited | 43817-135 | 43817-135-04 | 6 BLISTER PACK in 1 CARTON (43817-135-04) / 3 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (43817-135-03) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, ORALLY DISINTEGRATING;ORAL | Strength | EQ 5MG BASE | ||||
Approval Date: | Jan 11, 2017 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, ORALLY DISINTEGRATING;ORAL | Strength | EQ 10MG BASE | ||||
Approval Date: | Jan 11, 2017 | TE: | AB | RLD: | No |
Complete Access Available with Subscription